Why digital matters for neurodegeneration treatments
Author(s): Molly Andrews, UK Dementia Research Institute; Priya Kalia, SciTribe; Miranda Weston-Smith, BioBeat.
A critical time for AI, dementia and better brain health
Ahead of BioBeat24, Iraida Soria-Espinosa, Senior Innovation & Business Manager at UK DRI, and Miranda Weston-Smith, Founder of BioBeat, caught up with keynote speaker Zoe Kourtzi, Professor of Computational Cognitive Neuroscience at
Navigating biotech's changing landscape
BioBeat23 provided a platform for investors, entrepreneurs, and industry experts to delve into the evolving world of biotechnology. Against the backdrop of economic adversity, this gathering of minds shed light on the key mindsets and strategies required for success in the biotech industry. Organised by Miranda Weston-Smith, Founder of BioBeat, and Alisa Molotova, Investment Manager at Martlet…
BioBeat Summit: Connecting humanity and technology to improve health
Live-streamed to over 600 delegates from AstraZeneca’s new R&D Centre in Cambridge, UK, this year’s BioBeat Summit focused on optimising outcomes through digital innovation in clinical trials and beyond. Read a summary of the event here:
Biobeat Movers and Shakers report highlights top 30 trendsetters in UK life sciences
Released today by life sciences network BioBeat, the eighth annual Movers and Shakers in BioBusiness report highlights 30 trendsetters from across the UK who are tackling some of the biggest health challenges of our time.
AstraZeneca expert previews BioBeat21 Summit
In advance of the BioBeat21 Summit on 'Transforming medicine development through digital innovation' next month - to be live-streamed from the new AstraZeneca R&D Centre, Cambridge - Cristina Duran, AstraZeneca's Chief Digital Health Officer R&D, shares her thoughts on the digital health space.
Data-driven health for compassionate and ethical care
The BioBeat20 Summit, hosted in partnership with the Francis Crick Institute, brought together the life sciences community to explore the opportunities for adopting and investing in data-driven health. A global audience with more than 200 attendees from across the UK, USA, Brazil and Europe joined the virtual meeting on 17 November.
New report showcases resourceful leaders in UK bioscience for challenging times
Released today by BioBeat, the seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.
New report showcases 50 trailblazers shaping UK bioscience
Released today by BioBeat, the sixth annual 50 Movers and Shakers in BioBusiness report highlights the trailblazers and trendsetters shaping the future of the UK life sciences sector.
Next generation cell and gene therapies: fine tuning the promise
On 19 November, the UK BioBeat19 summit goes to Stevenage to discuss the potential of cell and gene therapy and how to accelerate these transformational medicines.
BioBeat unveils 2018’s 50 Movers and Shakers
A new report released today unveils 50 female leaders in healthcare business in the UK. Produced by BioBeat, 50 Movers and Shakers in BioBusiness 2018 emphasises the current role of women in leading, inspiring and innovating to ensure new technologies and treatments continue to improve UK research, health and society.*